In short: Good Distribution Practice (GDP) is the set of controls that keep a medicine’s quality intact between the manufacturer and the patient. In India, CDSCO’s guidelines on Good Distribution Practices for Pharmaceutical Products ask distributors to store products as the manufacturer specifies, temperature-map and monitor storage, issue stock first-expiry-first-out, run written recall and complaint procedures, segregate suspected spurious products, keep batch-wise records and inspect themselves every year.
Where the guideline comes from
The Central Drugs Standard Control Organisation (CDSCO) has published Guidelines on Good Distribution Practices for Pharmaceutical Products (document CDSCO/GDP.PP). The version on its website is marked as a draft for feedback, so treat it as the regulator’s stated expectation rather than a final rulebook. Licences, record-keeping and storage conditions themselves are already required under the Drugs Rules, 1945, and enforced by state drug control authorities.
Premises and storage
- Secure, well-maintained premises, with unauthorised people kept out.
- Separate, clearly marked areas for quarantined, returned, recalled and suspected spurious stock.
- Storage exactly as the manufacturer recommends, with records wherever conditions are critical. The draft asks for monitoring records to be kept for the product’s shelf life plus one year.
- Storage areas temperature-mapped “under representative conditions”, with sensors placed where temperatures swing most, and monitoring equipment calibrated at set intervals.
- First expiry, first out (FEFO): the stock that expires first is issued first, and near-expiry stock is checked regularly.
Transport
- Products moved in the conditions printed on their labels, in clean, suitable vehicles.
- Data loggers calibrated at least once a year.
- Any temperature excursion in transit reported to both the distributor and the recipient.
Returns, recalls and complaints
- Returned goods quarantined on arrival and released only after a documented, risk-based decision. Anything whose quality is in doubt is never re-sold.
- A written recall procedure with a named responsible person, reviewed every year, that can start “promptly and at any time”, and a final reconciliation of quantities delivered and recovered.
- A written complaints procedure that separates product complaints from distribution complaints, with root cause and corrective action recorded.
Spurious and substandard products
Suspected spurious, misbranded, adulterated or not-of-standard-quality products must be segregated, labelled not for sale, withdrawn from sale and reported to the regulator without delay, and must never re-enter the market. Staff training should cover how to spot them.
Records and self-inspection
Every receipt is recorded with the date, product, batch, quantity and supplier, and tamper-evident features are checked on arrival. The draft asks for documents to be kept for one year after the product’s expiry, and for an independent self-inspection at least once a year.
How RS Surgipharm applies GDP
Our Ahmedabad warehouse runs to written SOPs, with a temperature-mapped cold room at +2 °C to +8 °C, a cool room at +15 °C to +25 °C, round-the-clock monitoring with mobile alerts, FEFO issue, segregated holding areas and batch-wise records on every invoice. Our Quality page answers each area an auditor checks and lists the documents we can share.
Quick answers
- Is GDP mandatory for distributors in India?
- Licensing, storage conditions and record-keeping are required by the Drugs Rules, 1945. CDSCO’s GDP guideline sets out how the regulator expects distributors to meet them; the version on its website is a draft for feedback.
- How long should distributors keep records?
- The CDSCO draft guideline asks for distribution documents to be kept for one year after the product’s expiry, and storage-monitoring records for the product’s shelf life plus one year.
Sources
This guide is general information for healthcare professionals, procurement teams and patients, not medical, legal or regulatory advice. Rules change; confirm with the relevant authority.